Common human Toll-like receptor 9 polymorphisms and haplotypes: Association with atopy and functional relevance

Clinical and Experimental Allergy

Volumn 35, Issue 9, 2005, Pages 1147-1154

  Berghofer B ^a   Frommer, T ^a   Konig I R ^b   Ziegler, A ^b   Chakraborty, T ^a   Bein, G ^a   Hackstein, H ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Atopy; Cytokines; Haplotype; Polymorphism; TLR9

Indexed keywords

ALLERGEN; BACTERIAL DNA; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOLOGICAL ADJUVANT; TOLL LIKE RECEPTOR 9; VIRUS DNA; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE; TLR9 PROTEIN, HUMAN;

ALLERGY; ARTICLE; ASTHMA; ATOPY; BACTERIAL INFECTION; CANCER THERAPY; CPG ISLAND; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE PREDISPOSITION; EXON; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOTHERAPY; INTRON; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; RECEPTOR UPREGULATION; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TLR9 GENE; VACCINATION; BLOOD; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS; HYPERSENSITIVITY; IMMUNIZATION; IMMUNOLOGY; NONPARAMETRIC TEST; RISK FACTOR;

GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERSENSITIVITY; IMMUNIZATION; IMMUNOGLOBULIN E; INTERFERON TYPE II; OLIGODEOXYRIBONUCLEOTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE ANALYSIS, DNA; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 9;

EID: 33644811344     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02325.x     Document Type: Article

References (49)

1. Akira S Takeda K Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001 2 : 675 80.
2. Akira S Sato S. Toll-like receptors and their signaling mechanisms. Scand J Infect Dis 2003 35 : 555 62.
3. Krieg A. Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides. Curr Oncol Rep 2004 6 : 88 95.
4. Kadowaki N Ho S Antonenko S et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001 194 : 863 9.
5. Bauer S Kirschning CJ Hacker H et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001 98 : 9237 42.
6. Krug A Towarowski A Britsch S et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 2001 31 : 3026 37.
7. Hornung V Rothenfusser S Britsch S et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002 168 : 4531 7.
8. Ahmad-Nejad P Hacker H Rutz M Bauer S Vabulas RM Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol 2002 32 : 1958 68.
9. Latz E Schoenemeyer A Visintin A et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004 5 : 190 208.
10. Takeda K Kaisho T Akira S. Toll-like receptors. Annu Rev Immunol 2003 21 : 335 76.
11. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002 20 : 709 60.
12. Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 2004 4 : 249 58.
13. Siegal FP Kadowaki N Shodell M et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999 284 : 1835 7.
14. Krug A Rothenfusser S Hornung V et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 2001 31 : 2154 63.
15. Muller U Steinhoff U Reis LF et al. Functional role of type I and type II interferons in antiviral defense. Science 1994 264 : 1918 21.
16. Isaacs A Lindenmann J. Virus interference. I. The interferon. Proc R Soc London B Biol Sci 1957 147 : 258 67.
17. Kadowaki N Antonenko S Lau JY Liu YJ. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 2000 192 : 219 26.
18. Kadowaki N Liu YJ. Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum Immunol 2002 63 : 1126 32.
19. Heeg K Zimmermann S. CpG DNA as a Th1 trigger. Int Arch Allergy Immunol 2000 121 : 87 97.
20. Klinman DM. Therapeutic applications of CpG-containing oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev 1998 8 : 181 4.
21. Klinman DM Barnhart KM Conover J. CpG motifs as immune adjuvants. Vaccine 1999 17 : 19 25.
22. Carpentier AF Auf G Delattre JY. CpG-oligonucleotides for cancer immunotherapy: review of the literature and potential applications in malignant glioma. Front Biosci 2003 8 : e115 27.
23. Jahrsdorfer B Weiner GJ. CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy. Curr Opin Investig Drugs 2003 4 : 686 90.
24. Sur S Wild JS Choudhury BK Sur N Alam R Klinman DM. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 1999 162 : 6284 93.
25. Kline JN Waldschmidt TJ Businga TR et al. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 1998 160 : 2555 9.
26. Horner AA Widhopf GF Burger JA et al. Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells. J Allergy Clin Immunol 2001 108 : 417 23.
27. Dalpke A Zimmermann S Heeg K. Immunopharmacology of CpG DNA. Biol Chem 2002 383 : 1491 500.
28. Zimmermann S Egeter O Hausmann S et al. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol 1998 160 : 3627 30.
29. Elkins KL Rhinehart-Jones TR Stibitz S Conover JS Klinman DM. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol 1999 162 : 2291 8.
30. Chiaramonte MG Hesse M Cheever AW Wynn TA. CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism. J Immunol 2000 164 : 973 85.
31. Walker PS Scharton-Kersten T Krieg AM et al. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms. Proc Natl Acad Sci USA 1999 96 : 6970 5.
32. Ashkar AA Bauer S Mitchell WJ Vieira J Rosenthal KL. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J Virol 2003 77 : 8948 56.
33. Du X Poltorak A Wei Y Beutler B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 2000 11 : 362 71.
34. Chuang TH Ulevitch RJ. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 2000 11 : 372 8.
35. Lazarus R Klimecki WT Raby BA et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 2003 81 : 85 91.
36. Noguchi E Nishimura F Fukai H et al. An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 2004 34 : 177 83.
37. Excoffier L Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995 12 : 921 7.
38. Schaid DJ Rowland CM Tines DE Jacobson RM Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002 70 : 425 34.
39. Bohle B. CpG motifs as possible adjuvants for the treatment of allergic diseases. Int Arch Allergy Immunol 2002 129 : 198 203.
40. Iwasaki A Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004 5 : 987 95.
41. Cowdery JS Chace JH Yi AK Krieg AM. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol 1996 156 : 4570 5.
42. Ballas ZK Rasmussen WL Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996 157 : 1840 5.
43. Davis HL Weeratna R Waldschmidt TJ et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 1998 160 : 870 6.
44. Parronchi P Brugnolo F Annunziato F et al. Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors. J Immunol 1999 163 : 5946 53.
45. Van Uden JH Tran CH Carson DA Raz E. Type I interferon is required to mount an adaptive response to immunostimulatory DNA. Eur J Immunol 2001 31 : 3281 9.
46. Bufe A Gehlhar K Grage-Griebenow E Ernst M. Atopic phenotype in children is associated with decreased virus-induced interferon-alpha release. Int Arch Allergy Immunol 2002 127 : 82 8.
47. Gruschwitz MS Peters KP Heese A Stosiek N Koch HU Hornstein OP. Effects of interferon-alpha-2b on the clinical course, inflammatory skin infiltrates and peripheral blood lymphocytes in patients with severe atopic eczema. Int Arch Allergy Immunol 1993 101 : 20 30.
48. Gratzl S Palca A Schmitz M Simon HU. Treatment with IFN-alpha in corticosteroid-unresponsive asthma. J Allergy Clin Immunol 2000 105 : 1035 6.
49. Smirnova I Mann N Dols A et al. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci USA 2003 100 : 6075 80.